The Blueprint Translational Research Team

A preclinical to clinical research team at the @ottawahospital, working to accelerate #bench2bedside translation.

[The Blueprint Translational Research Team @Team_Blueprint]

New @BioCanRx funded work in Transfusion Medicine Reviews!
Our IPD meta-analysis (89 trials, 2,331 pts) reveals key modifiers of CAR T-cell efficacy & safety:
✅ Allogeneic > Autologous
🎯 CD19 combos > CD19 alone
⚠️ Bridging therapy ↓ response
🔗 Read: https://t.co/reOhAC4Zi5

[eLife - the journal @eLife]

The importance of including patient voices when appraising new drug treatments for strokes is backed by meta-analyses of several studies.
https://t.co/o2s6vbT0HC

[The Blueprint Translational Research Team @Team_Blueprint]

New in @eLife 🧠
CCR5 antagonists show promise for stroke treatment in preclinical studies — but the evidence has gaps.
Our patient-led systematic review reveals opportunities & limitations for clinical translation.
🧪➡️👥
Read more: https://t.co/0Zvqq87PA7
#StrokeRecovery #CCR5

[The Blueprint Translational Research Team @Team_Blueprint]

We're excited to be sharing another edition of our LabPartners newsletter, highlighting our work to champion patient engagement in preclinical laboratory-based research! Read the full newsletter here: https://t.co/R33oaI6Gzz

[The Blueprint Translational Research Team @Team_Blueprint]

You can also hear our PhD candidate, Matthew Jeffers, speak about this work at Plenary 3 of the @StemCellNetwork #TMM2024 meeting on November 5 in Montreal. Hope to see you there!

[The Blueprint Translational Research Team @Team_Blueprint]

Interested in what #preclinical 🐭 evidence is needed to advance your new #celltherapy 🔬 into #clinicaltrials 👩‍🔬? We synthesized key guidance from over 60 regulatory agencies worldwide to help accelerate your research. https://t.co/3h3ZK5lgvM

[The Blueprint Translational Research Team @Team_Blueprint]

@BMCMedicine @uOttawa_SEPH @StemCellNetwork @ISCTglobal @OttawaHospital @OttMethodsCentr @ManojLalu @uOttawaMed

[The Blueprint Translational Research Team @Team_Blueprint]

Interested in what #preclinical 🐭 evidence is needed to advance your new #celltherapy 🔬 into #clinicaltrials 👩‍🔬? We synthesized key guidance from over 60 regulatory agencies worldwide to help accelerate your research. https://t.co/3h3ZK5lgvM

[The Blueprint Translational Research Team @Team_Blueprint]

We're excited to be sharing the second edition of our LabPartners newsletter, highlighting our work to champion patient engagement in preclinical laboratory-based research! Read the full newsletter here: https://t.co/pFIs3vPnH6

[The Blueprint Translational Research Team @Team_Blueprint]

The Blueprint Translational Research Team at the Ottawa Hospital Research Institute has created a policy brief outlining how patient engagement can be promoted in preclinical laboratory-based research! Read the full policy brief HERE: https://t.co/QJHKubcIlB

[The Blueprint Translational Research Team @Team_Blueprint]

The Blueprint Team is excited to be launching a newsletter focused on our program to facilitate patient engagement in preclinical laboratory research! Available here: https://t.co/CQSYeRFhXn

[The Blueprint Translational Research Team @Team_Blueprint]

The Blueprint Team is excited to be launching a newsletter focused on our program to facilitate patient engagement in preclinical laboratory research! Available here: https://t.co/CQSYeRFhXn

[The Blueprint Translational Research Team @Team_Blueprint]

Great presentations from PhD candidates Matthew Jeffers and Dr. Michael Verret at SEPH Research Day! 🤩

[The Blueprint Translational Research Team @Team_Blueprint]

Dr. Michael Verret's work was highlighted in the SPOR December newsletter. What an excellent example of patient engagement in opioid minimization research! 🎉 https://t.co/s5OYgbY8K4

[The Blueprint Translational Research Team @Team_Blueprint]

@BenjaminNHLam had the opportunity to attend the Post Graduate Assembly in Anesthesiology #PGA77 conference in New York City and presented his research! 🎉Way to go Benjamin!

[The Blueprint Translational Research Team @Team_Blueprint]

@ulf_toelch

[The Blueprint Translational Research Team @Team_Blueprint]

Dr. Ulf Tölch, visiting scientist from Berlin, is presenting this Friday Dec 15 @ 1pm (in-person). If you have interest in designing preclinical studies in order to help increase potential for translation to human research, you won't want to miss this presentation!

[The Blueprint Translational Research Team @Team_Blueprint]

@CIHR_IRSC @uOttawa_SEPH @uOttawaMed @MitacsCanada

[The Blueprint Translational Research Team @Team_Blueprint]

Congrats 🎉 to Blueprint #VanierCanada scholar Matthew Jeffers and @CCAC_CCPA post-doc @AileenMacLellan in this new #PLOSBiology perspective on how we can improve prospective registration of animal studies!
Thanks to @IanDGraham1 for his mentorship in #knowledgetranslation!

[PLOS Biology @PLOSBiology]

Prospective #registration of animal studies could improve research transparency and reduce redundancy.

@ManojLalu @AileenMacLellan @Marc_T_Avey @JuliaMenon18 &co argue that registration should be integrated as part of animal #ethics review.

#PLOSBiology

https://t.co/xwoozawq3H

[uOttawa | Innovation @uOttawaResearch]

Un grand bravo aux boursiers #VanierCanada 2023 de l’@uOttawa qui cherchent à développer des solutions proactives en santé et à améliorer notre qualité de vie grâce à leurs projets de recherche novateurs. Félicitations!

[The Blueprint Translational Research Team @Team_Blueprint]

Blueprint's very own, Matthew Jeffers, highlighted here! Outstanding work and congratulations to all #VanierCanada Scholars!👏👏👏👏

[uOttawa | Innovation @uOttawaResearch]

A round of applause for @uOttawa’s 2023 #VanierCanada Scholars who are striving to develop proactive health solutions and improve our quality of life through their innovative research projects. Congratulations to all!